ArticleBlood advances2023
Jeong H, Cho H, Kim H, et al. Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis. Blood Adv. 2021;5(8):2142-2152.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.